Ipamorelin is described in the research literature as a selective agonist of the ghrelin receptor (also called the growth-hormone-secretagogue receptor)
DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD(+) depletion in experimental atrial fibrillation
Each type of medication affects the body differently, which can influence fertility outcomes and the management of treatments
Stopping medication may lead to increased appetite and weight regain for some people, especially if the underlying drivers of weight gain are still present
CrossRef The diamond approach to personalized drug treatment of heart failure with reduced ejection fraction Hongbo Gan, Heng Tang, Yujie Huang, Dan Wang, Peng Pu, Zhong Zuo Reviews in Cardiovascular Medicine.2021;[Epub] CrossRef Lowering the risk of gout: Another benefits from the use of sodiumglucose cotransporter 2 inhibitors Wayne HH Sheu Journal of Diabetes Investigation.2020
BJOG: An International Journal of Obstetrics & Gynaecology, 118(11), 1314-1323
